Inventor · disambiguated record
Atul J. Butte
Also filed as: BUTTE ATUL · BUTTE ATUL J · BUTTE ATUL JANARDHAN
8 granted patents·17 pending applications·38 citations·filing 2004–2022
82Inventor score
Top patents by PatentIndex Score
25 records- 0188US7576052B2Methods and compositions for modulating adipocyte functionJOSLIN DIABETES CENTER INC·Filed 2004·Granted Aug 18, 2009·30 cites·21 claims
- 0275US8178492B2Methods and compositions for modulating adipocyte functionKAHN C RONALD·Filed 2009·Granted May 15, 2012·1 cites·1 claims
- 0374US8700337B2Method and system for computing and integrating genetic and environmental health risks for a personal genomeDUDLEY JOEL T·Filed 2011·Granted Apr 15, 2014·4 cites·16 claims
- 0471US9132169B2Methods and compositions for modulating adipocyte functionKAHN C RONALD·Filed 2012·Granted Sep 15, 2015·1 cites·6 claims
- 0570US11768208B2Protein and gene biomarkers for rejection of organ transplantsUNIV LELAND STANFORD JUNIOR·Filed 2021·Granted Sep 26, 2023·0 cites·16 claims
- 0663US10119959B2Method of assaying an individual for immune impairmentSHEN ORR SHAI S·Filed 2011·Granted Nov 6, 2018·2 cites·10 claims
- 0762US2019172556A1Method and System for Assessment of Regulatory Variants in a GenomeUNIV LELAND STANFORD JUNIOR·Filed 2018·Application pending·0 cites
- 0859US2024226126A1Compositions for treatment of psoriasisUNIV LELAND STANFORD JUNIOR·Filed 2022·Application pending·0 cites
- 0957US9535075B2Protein and gene biomarkers for rejection of organ transplantsSARWAL MINNIE M·Filed 2011·Granted Jan 3, 2017·0 cites·23 claims
- 1056US2017227549A1Protein and gene biomarkers for rejection of organ transplantsUNIV LELAND STANFORD JUNIOR·Filed 2016·Application pending·0 cites
- 1149US2018373838A1Method and System for the Use of Biomarkers for Regulatory Dysfunction in DiseaseUNIV LELAND STANFORD JUNIOR·Filed 2018·Application pending·0 cites
- 1247US2016291024A1Biomarkers for Ovarian CancerUNIV LELAND STANFORD JUNIOR·Filed 2014·Application pending·0 cites
- 1347US2013144636A1Method and System for Predicting Adverse Drug Reactions Using BioAssay DataPOULIOT YANNICK·Filed 2011·Application pending·0 cites
- 1443US2015133390A1Identification of New Therapeutic Uses for Known Therapeutic AgentsUNIV LELAND STANFORD JUNIOR·Filed 2013·Application pending·0 cites
- 1541US2013090909A1Method And System For Functional Evolutionary Assessment Of Genetic VariantsDUDLEY JOEL T·Filed 2012·Application pending·0 cites
- 1640US2016018413A1Methods of Prognosing PreeclampsiaUNIV LELAND STANFORD JUNIOR·Filed 2014·Application pending·0 cites
- 1738US9946835B2Method and system for the use of biomarkers for regulatory dysfunction in diseaseKARCZEWSKI KONRAD·Filed 2012·Granted Apr 17, 2018·0 cites·14 claims
- 1838US2012077689A1Compartment-Specific Non-HLA Targets for Diagnosis and Prediction of Graft OutcomeSARWAL MINNIE M·Filed 2010·Application pending·0 cites
- 1938US2017182040A1Epithelial ion channel (enac) blockers to treat psoriasisUNIV LELAND STANFORD JUNIOR·Filed 2015·Application pending·0 cites
- 2038US2017198292A1Methods and Compositions for Modulating Lung Cancer Tumor Initiating Cells (TIC), and Oxytocin Receptor (OXTR) Modulatory Agents for Use in Practicing the SameUNIV LELAND STANFORD JUNIOR·Filed 2015·Application pending·0 cites
- 2137US2015099655A1Methods and Compositions for Providing a Preeclampsia AssessmentUNIV LELAND STANFORD JUNIOR·Filed 2013·Application pending·0 cites
- 2236US2012165207A1Methods for Monitoring Allograft RejectionBUTTE ATUL J·Filed 2010·Application pending·0 cites
- 2335US2013071408A1Methods for Diagnosis and Treatment of Non-Insulin Dependent Diabetes MellitusBUTTE ATUL J·Filed 2011·Application pending·0 cites
- 2433US2012076797A1Modulation of kit signaling and hematopoietic cell development by IL-4 receptor modulationBUTTE ATUL J·Filed 2011·Application pending·0 cites
- 2533US2017224683A1Treatment of melanoma by blocking benzamil sensitive ion channels/exchangersUNIV LELAND STANFORD JUNIOR·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →